Supreme Court: General Fraud Allegations Cannot Extend Limitation under Section 74 CGST Act  ||  SC: ‘No Coercive Steps’ Order Cannot Restrain Filing of Charge Sheet  ||  Chhattisgarh HC: Maintenance for Autistic Child May Continue Beyond 18 Until Self-Sufficient  ||  P&H HC: 45-Day Delay in Informing Detenue of Representation Right Violates Article 22(5)  ||  Rajasthan HC Bars Courts from Protecting those Responsible for Building Defects at their Own Peril  ||  Allahabad HC: Clarification Issued Before Decision Applies to Pending Tender Complaints  ||  Allahabad HC: Father’s Custody Cannot be Denied without Proof of Guardianship Unfitness  ||  Bombay High Court: Each Petitioner Must Pay Court Fee Where Causes of Action are Separate  ||  P&H High Court: Counsel’s Ignorance of Readily Available Prior Litigation Amounts to Dereliction  ||  SC: Amendments to Government Orders Must Be Construed Fairly to Prevent Hardship    

Search Results for Tag : Natco Pharma

News

Natco Settles Patent Dispute with Gilead in a US Court(15.12.2015)

Natco Pharma along with its partner Alvogen has settled the patent infringement suit with Gilead Sciences Inc. and others over “Tamiflu” in a US court.....

Tags : Natco Pharma , Alvogen, Tamiflu, Patent Dispute



U.S. PTO Rules in Favour of Mylan(29.08.2016)

U.S.Patent and Trademark Office (PTO) has ruled in the favour of Natco Pharma’s marketing partner Mylan, with regard to patent claims pertaining to mu.....

Tags : U.S.Patent and Trademark Office, Natco Pharma, patent claims



Delhi High Court Awards Natco Pharma Interim Relief in BMS Patents Case(23.07.2019)

Delhi High Court has awarded interim relief to the Hyderabad-based Natco Pharma Ltd in a fresh patents battle, with the court setting aside an injunc.....

Tags : Delhi High Court, Natco Pharma



Celgene Settles Revlimid Patent Dispute with Natco Pharma(24.12.2015)

Natco Pharma Ltd and partner Allergan Plc has settled dispute with US-based drug maker Celgene Corp. in the patent infringement case of the latter’s c.....

Tags : Natco Pharma, Celgene Corp, Revlimid Patent



Disclaimer | Copyright 2026 - All Rights Reserved